GlassScriptPhysician profile
Brett M Harrison
NPI 1710987367
$357.73
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $91.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $44.89 | 2019 | |
| Eisai INC. | $44.87 | 2019 | |
| Celgene Corporation | $43.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.08 | 2019-2020 | |
| Incyte Corporation | $38.01 | 2019 | |
| Tesaro, INC. | $36.92 | 2019 | |
| Ethicon US, LLC | $32.52 | 2020 | |
| Merck Sharp & Dohme LLC | $31.79 | 2019-2020 | |
| Davol INC. | $16.70 | 2020 | |
| Lilly USA, LLC | $15.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.78 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.